Home/Filings/4/0001209191-18-007139
4//SEC Filing

Nicholson John 4

Accession 0001209191-18-007139

CIK 0000906709other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 6:03 PM ET

Size

7.2 KB

Accession

0001209191-18-007139

Insider Transaction Report

Form 4
Period: 2018-01-31
Nicholson John
SVP & Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2018-01-31$11.34/sh+120,000$1,360,800392,536 total
  • Exercise/Conversion

    Stock Option

    2018-01-31120,0000 total
    Exercise: $11.34From: 2014-02-01Exp: 2018-02-01Common Stock (120,000 underlying)
Footnotes (1)
  • [F1]This transaction was made for stock options scheduled to expire on February 1, 2018.

Issuer

NEKTAR THERAPEUTICS

CIK 0000906709

Entity typeother

Related Parties

1
  • filerCIK 0001420766

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 6:03 PM ET
Size
7.2 KB